Advertisement
Screener

bioAffinity Technologies, Inc. (BIAF) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

2.8 / 5 stars · 68/120 Roast Me

bioAffinity Technologies, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

bioAffinity Technologies, Inc. (BIAF) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $724.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.

Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2023-03-31

  • bioAffinity Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2022-12-31 was $0.00.
  • bioAffinity Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2022 was $724.00K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$724.00K
10-K · filed 2023-03-31
2022-09-30$724.00K
10-Q · filed 2022-11-14
2021-12-31$3.29M
10-Q · filed 2022-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14